Literature DB >> 14647916

[Neuroprotection in brain tumors. Good sense or nonsense from the pathophysiological viewpoint?].

B Schaller1.   

Abstract

The hemodynamic and metabolic state of peritumoral brain tissue is not well understood, especially with subtotal or total, extraluminal compression of the carotid artery or other main intracranial vessels of the central nervous system. Possibly, parallels can be drawn from the knowledge in chronically malperfused brain tissue of atherosclerotic disease in sub- or nearly total stenosis of the internal carotid artery. From this point of view, it seems that the CBF/CBV quotient and oxygen extraction rate represent an additional diagnostic method-if needed in combination with the well-established balloon occlusion test-to help to better characterize the grade of still viable peritumoral brain tissue. The therapeutic strategy for possible pharmacological neuroprotection should be related to these parameters. It remains a matter of debate whether this clinical phenomenon will be one of the therapeutic domains influenced by ischemic preconditioning in the near-future.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14647916     DOI: 10.1007/s00115-003-1587-1

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  10 in total

1.  Ischaemic tolerance: a window to endogenous neuroprotection?

Authors:  Bernhard Schaller; Rudolf Graf; Andreas H Jacobs
Journal:  Lancet       Date:  2003-09-27       Impact factor: 79.321

2.  Transcription factor HIF-1 is a necessary mediator of the pasteur effect in mammalian cells.

Authors:  T N Seagroves; H E Ryan; H Lu; B G Wouters; M Knapp; P Thibault; K Laderoute; R S Johnson
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

3.  Premeatal and retromeatal cerebellopontine angle meningioma. Two distinct clinical entities.

Authors:  B Schaller; A Merlo; O Gratzl; R Probst
Journal:  Acta Neurochir (Wien)       Date:  1999       Impact factor: 2.216

Review 4.  Cerebral ischemic preconditioning. An experimental phenomenon or a clinical important entity of stroke prevention?

Authors:  B Schaller; R Graf
Journal:  J Neurol       Date:  2002-11       Impact factor: 4.849

Review 5.  Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology.

Authors:  G L Semenza
Journal:  Trends Mol Med       Date:  2001-08       Impact factor: 11.951

6.  Effect of nimodipine on regional cerebral glucose metabolism in patients with acute ischemic stroke as measured by positron emission tomography.

Authors:  W D Heiss; V Holthoff; G Pawlik; M Neveling
Journal:  J Cereb Blood Flow Metab       Date:  1990-01       Impact factor: 6.200

Review 7.  Brain tumor and seizures: pathophysiology and its implications for treatment revisited.

Authors:  Bernhard Schaller; Stephan J Rüegg
Journal:  Epilepsia       Date:  2003-09       Impact factor: 5.864

8.  Metabolic and hemodynamic aspects of peritumoral low-density areas in human brain tumor.

Authors:  A Hino; Y Imahori; H Tenjin; N Mizukawa; S Ueda; K Hirakawa; H Nakahashi
Journal:  Neurosurgery       Date:  1990-04       Impact factor: 4.654

9.  Increased expression of hypoxia inducible factor-1alpha in rat and human prostate cancer.

Authors:  H Zhong; F Agani; A A Baccala; E Laughner; N Rioseco-Camacho; W B Isaacs; J W Simons; G L Semenza
Journal:  Cancer Res       Date:  1998-12-01       Impact factor: 12.701

10.  Adventures in the pathophysiology of brain ischemia: penumbra, gene expression, neuroprotection: the 2002 Thomas Willis Lecture.

Authors:  Myron D Ginsberg
Journal:  Stroke       Date:  2003-01       Impact factor: 7.914

  10 in total
  5 in total

Review 1.  Molecular imaging of brain tumors: a bridge between clinical and molecular medicine?

Authors:  B J Schaller; M Modo; M Buchfelder
Journal:  Mol Imaging Biol       Date:  2007 Mar-Apr       Impact factor: 3.488

2.  Molecular medicine successes in neuroscience.

Authors:  Bernhard Schaller; Jan F Cornelius; Nora Sandu
Journal:  Mol Med       Date:  2008 Jul-Aug       Impact factor: 6.354

Review 3.  Stem cell transplantation in brain tumors: a new field for molecular imaging?

Authors:  Nora Sandu; Bernhard Schaller
Journal:  Mol Med       Date:  2010-06-30       Impact factor: 6.354

Review 4.  Current molecular imaging of spinal tumors in clinical practice.

Authors:  Nora Sandu; Gabriele Pöpperl; Marie-Elisabeth Toubert; Toma Spiriev; Belachew Arasho; Mikael Orabi; Bernhard Schaller
Journal:  Mol Med       Date:  2011-01-03       Impact factor: 6.354

5.  Molecular imaging of stem cell therapy in brain tumors: a step towards personalized medicine.

Authors:  Nora Sandu; Bernhard Schaller
Journal:  Arch Med Sci       Date:  2012-09-08       Impact factor: 3.318

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.